chr16-20349037-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003361.4(UMOD):​c.264C>T​(p.Gly88Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0129 in 1,598,442 control chromosomes in the GnomAD database, including 839 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 151 hom., cov: 33)
Exomes 𝑓: 0.011 ( 688 hom. )

Consequence

UMOD
NM_003361.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.63

Publications

7 publications found
Variant links:
Genes affected
UMOD (HGNC:12559): (uromodulin) The protein encoded by this gene is the most abundant protein in mammalian urine under physiological conditions. Its excretion in urine follows proteolytic cleavage of the ectodomain of its glycosyl phosphatidylinosital-anchored counterpart that is situated on the luminal cell surface of the loop of Henle. This protein may act as a constitutive inhibitor of calcium crystallization in renal fluids. Excretion of this protein in urine may provide defense against urinary tract infections caused by uropathogenic bacteria. Defects in this gene are associated with the renal disorders medullary cystic kidney disease-2 (MCKD2), glomerulocystic kidney disease with hyperuricemia and isosthenuria (GCKDHI), and familial juvenile hyperuricemic nephropathy (FJHN). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2013]
UMOD Gene-Disease associations (from GenCC):
  • autosomal dominant medullary cystic kidney disease with or without hyperuricemia
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • glomerulocystic kidney disease with hyperuricemia and isosthenuria
    Inheritance: AD Classification: DEFINITIVE Submitted by: Laboratory for Molecular Medicine
  • familial juvenile hyperuricemic nephropathy type 1
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal dominant medullary cystic kidney disease with hyperuricemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 16-20349037-G-A is Benign according to our data. Variant chr16-20349037-G-A is described in ClinVar as Benign. ClinVar VariationId is 259046.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.63 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0972 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UMODNM_003361.4 linkc.264C>T p.Gly88Gly synonymous_variant Exon 3 of 11 ENST00000396138.9 NP_003352.2 P07911-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UMODENST00000396138.9 linkc.264C>T p.Gly88Gly synonymous_variant Exon 3 of 11 5 NM_003361.4 ENSP00000379442.5 P07911-1X6RBG4
UMODENST00000396134.6 linkc.363C>T p.Gly121Gly synonymous_variant Exon 4 of 12 2 ENSP00000379438.2 P07911-5

Frequencies

GnomAD3 genomes
AF:
0.0281
AC:
4273
AN:
152264
Hom.:
151
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0634
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0485
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0614
Gnomad SAS
AF:
0.105
Gnomad FIN
AF:
0.000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.0167
GnomAD2 exomes
AF:
0.0311
AC:
6901
AN:
222184
AF XY:
0.0316
show subpopulations
Gnomad AFR exome
AF:
0.0646
Gnomad AMR exome
AF:
0.0699
Gnomad ASJ exome
AF:
0.000210
Gnomad EAS exome
AF:
0.0576
Gnomad FIN exome
AF:
0.00165
Gnomad NFE exome
AF:
0.000711
Gnomad OTH exome
AF:
0.0166
GnomAD4 exome
AF:
0.0113
AC:
16376
AN:
1446060
Hom.:
688
Cov.:
39
AF XY:
0.0134
AC XY:
9649
AN XY:
718098
show subpopulations
African (AFR)
AF:
0.0651
AC:
2150
AN:
33040
American (AMR)
AF:
0.0678
AC:
2859
AN:
42146
Ashkenazi Jewish (ASJ)
AF:
0.0000774
AC:
2
AN:
25828
East Asian (EAS)
AF:
0.0542
AC:
2098
AN:
38716
South Asian (SAS)
AF:
0.0934
AC:
7836
AN:
83884
European-Finnish (FIN)
AF:
0.00190
AC:
99
AN:
52104
Middle Eastern (MID)
AF:
0.00626
AC:
36
AN:
5752
European-Non Finnish (NFE)
AF:
0.000309
AC:
341
AN:
1104694
Other (OTH)
AF:
0.0159
AC:
955
AN:
59896
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1273
2546
3819
5092
6365
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0281
AC:
4285
AN:
152382
Hom.:
151
Cov.:
33
AF XY:
0.0305
AC XY:
2273
AN XY:
74522
show subpopulations
African (AFR)
AF:
0.0636
AC:
2644
AN:
41590
American (AMR)
AF:
0.0485
AC:
742
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.0617
AC:
320
AN:
5184
South Asian (SAS)
AF:
0.105
AC:
506
AN:
4832
European-Finnish (FIN)
AF:
0.000941
AC:
10
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000426
AC:
29
AN:
68044
Other (OTH)
AF:
0.0161
AC:
34
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
202
404
607
809
1011
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0142
Hom.:
55
Bravo
AF:
0.0319
Asia WGS
AF:
0.0740
AC:
258
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 14, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial juvenile hyperuricemic nephropathy type 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
3.1
DANN
Benign
0.55
PhyloP100
2.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77875418; hg19: chr16-20360359; COSMIC: COSV56779667; COSMIC: COSV56779667; API